Micro Imaging Technology Announces an OEM Agreement With JMAR Technologies

Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that it has entered into an OEM supply agreement with JMAR Technologies, Inc. ("JMAR"). MIT's system for the rapid identification of E. coli, Listeria, Salmonella and other pathogens will be purchased and offered as an option with JMAR's BioSentry(TM) product line.

Michael Brennan, MIT's Chairman, stated that, "The combined technologies have a wide-ranging impact; JMAR's BioSentry(TM) instantly determines if there is a contaminant within a water supply and, within minutes after the contaminant is isolated, the accompanying MIT system will identify the specific species of bacteria, protozoa, fungi or other parasite present in the water. This agreement enables JMAR to sell MIT's table-top, rapid microbial identification system either as a complement to its BioSentry(TM) Water Monitoring System or as a stand-alone unit for customer laboratory sample evaluation. MIT expects to supply numerous systems over the next eighteen months with initial deliveries in January."

About JMAR:

JMAR is a leading innovator in the development of laser-based technology and x-ray processes for nano-scale imaging, analysis and fabrication. The Company is leveraging more than a decade of laser and photonic research to develop a portfolio of products with commercial applications in rapidly growing industries, while continuing to carry out research and development for the U.S. Government.

JMAR's flagship product, BioSentry(TM), is a patented contamination warning system for waterborne microorganisms. BioSentry(TM) was developed by Sensor Technologies, Inc. -- a division of JMAR -- and uses laser-based, multi-angle light scattering technology to provide continuous, on-line, real-time monitoring for harmful microorganisms. BioSentry(TM) is targeted toward a number of applications across multiple markets, including homeland security, the cruise ship and beverage industries, pharmaceutical companies, and municipal water utilities.

About Micro Imaging Technology:

MIT has developed and patented a laser-based technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT system is non-biological, does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis and combines extremely low test costs and fast completion times with very simple operating procedures.

MIT has demonstrated the ability to detect and identify, within minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, Shigella and other pathogenic bacteria and protozoa; including Cryptosporidium and Giardia. The identification process has been tested and verified by North American Science Associates, Inc. (NAMSA), an independent and internationally recognized testing and certification laboratory. The NAMSA Test Report, available from the Company, confirms the accuracy, speed and efficiency of the MIT system over conventional processes.

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

FOR FURTHER INFORMATION, CONTACT: Michael Brennan Chairman Micro Imaging Technology, Inc. Email: Email Contact Phone: (805) 557-0614